← All indications
Colitis, Ulcerative
Inflammation of the COLON that is predominantly confined to the MUCOSA. Its major symptoms include DIARRHEA, rectal BLEEDING, the passage of MUCUS, and ABDOMINAL PAIN.
Drugs by status
Approved for this indication (25)
Phase 4 trials (44)
- polyethylene glycol
- trifluridine
- bezlotoxumab
- vsl #3
- carotegrast methyl
- vitamin c
- omeprazole
- filgotinib
- sodium picosulfate
- dextromethorphan
- midazolam
- thiopurine
- oxygen
- losartan
- procaine benzylpenicillin
- vancomycin
- autologous microbiome
- roflumilast
- metronidazole
- ustekinumab
- magnesium citrate
- varicella zoster virus glycoprotein e antigen
- gentamicin
- tacrolimus
- cyclosporine
- tofacitinib
- lactobacillus delbrueckii
- escherichia coli nissle 1917
- human fecal microbiota
- bisacodyl
- +14 more
Phase 3 trials (50)
- Andrographis paniculata
- acetylsalicylic acid
- ringer's lactate
- rosuvastatin
- cobitolimod
- mercaptopurine
- risankizumab
- hydroxyethyl starch
- ferric carboxymaltose
- frondanol
- tev-48574
- prednisolone
- Andecaliximab
- pra023
- deligoparin
- beta-glucans
- loperamide
- guselkumab
- iron dextran
- fumaric acid esters
- ontamalimab
- tetomilast
- agaricus blazei murill
- spesolimab
- valganciclovir
- thalidomide
- tirzepatide
- levocarnitine
- obefazimod
- sucrosomial iron
- +20 more
Phase 2 trials (176)
- Hydroxytryptophan
- cbp-307
- altb-268
- dersalazine
- oprx-106
- ubiquinone
- bifidobacterium animalis
- tetracycline
- rebamipide
- pl8177
- ceftazidime
- bbt-401-1s
- pf-00547659
- mt-501
- lactobacillus gasseri
- sotrastaurin
- ceftriaxone
- brazikumab
- empagliflozin
- top1288
- ksp-0243
- pemigatinib
- hemay005
- hydroxocobalamin
- ore-1001
- gb004
- elubrixin
- he3286
- qbeco
- pur 0110
- +146 more
Phase 1 trials (68)
- maltodextrin
- indomethacin
- danshen
- ropinirole
- apixaban
- apvo210
- gsk4381406
- solcitinib
- albumin (Human)
- mb-001
- lmt503
- mk-6194
- bovine immunoglobin
- jnj-66525433
- avx 470
- inv-101
- abi-m201
- ro7049665
- tak-988
- microbiota
- platelet-rich plasma
- warfarin
- bms-986184
- pf-07054894
- ak101
- enterococcus faecium
- cd7 car-t cell
- oprelvekin
- mb310
- thrombin
- +38 more
Other trials (48)
- ergocalciferol
- lactobacillus casei
- autologous fecal microbiota
- fatty acid
- kb295
- calcitonin salmon
- clavulanate
- l-glutamine
- fructan
- selenomethionine se-75
- mare milk
- acacia
- lactobacillus plantarum
- cow milk
- pomegranate
- resistant starch
- sulfamethoxazole
- mebendazole
- alpha-lipoic acid
- silymarin
- trimethoprim
- rifaximin
- enc1018
- clarithromycin
- soybean
- ecologic 825
- icosapent ethyl
- Streptococcus thermophilus
- kushen
- cherry
- +18 more
Organizations
Organization Involved with Phase 4 Indications (83)
- AbbVie
- Shire
- Bausch Health Companies
- Pfizer
- Celltrion
- Fundación Pública Andaluza
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- Huazhong University of Science and Technology
- University of Pennsylvania
- University of Pittsburgh
- Boston University
- Centro Hospitalar Lisboa Ocidental
- University of London
- Diakonhjemmet Hospital
- University of Washington
- Grupo de Estudo da Doença Inflamatória Intestinal
- Guangzhou Medical University
- Imelda Hospital, Bonheiden
- Kliniken im Naturpark Altmuehltal
- McMaster University
- Nanjing Medical University
- Northwestern University
- Onze Lieve Vrouw Hospital
- Postgraduate Institute of Medical Education and Research
- The Baruch Padeh Medical Center, Poriya
- Universidad Autonoma de Madrid
- University of Groningen
- University of Melbourne
- University of Seville
- University of Adelaide
- +53 more
Organization Involved with Phase 3 Indications (94)
- Zeria Pharmaceutical
- Alizyme
- Eisai
- Facet Biotech
- Theravance
- Celgene
- Millennium Pharmaceuticals
- Bristol-Myers Squibb
- Galapagos NV
- Roche
- Astellas
- Gilead Sciences
- Centocor
- Eli Lilly
- Tillotts Pharma
- PDL BioPharma
- Arena Pharmaceuticals
- EMET Pharmaceuticals, LLC
- INC Research
- InDex Pharmaceuticals
- Kissei Pharmaceuticals
- Leadiant Biosciences, Inc.
- Parexel
- Shield Therapeutics
- Vifor Inc.
- Boehringer Ingelheim
- EA Pharma Co., Ltd.
- Eagle Pharmaceuticals, Inc.
- Otsuka
- ZonMw: The Netherlands Organisation for Health Research and Development
- +64 more
Organization Involved with Phase 2 Indications (158)
- Abivax S.A.
- Incyte
- AltruBio
- ActoGeniX
- Amgen
- Merck Serono
- Genentech
- MedImmune
- Sanofi
- Biogen
- AM-Pharma
- Novartis
- Allergan
- Athersys, Inc
- Bayer
- BioLineRx, Ltd.
- Cerimon Pharmaceuticals
- GlaxoSmithKline
- Hamilton Health Sciences Corporation
- Harbor Therapeutics
- Hemay Pharmaceutical PTY. LTD.
- Holy Stone Healthcare Co., Ltd
- Immune Pharmaceuticals
- Ionis Pharmaceuticals, Inc.
- Kyowa Hakko Kirin
- Lexicon Pharmaceuticals
- Lipid Therapeutics GmbH
- LG
- Lycera Corp.
- Natrogen Therapeutics International, Inc
- +128 more
Organization Involved with Phase 1 Indications (29)
- Sirtris Pharmaceuticals
- Human Genome Sciences
- Aptevo Therapeutics
- Wyeth
- Avaxia Biologics
- NuBiyota
- VHsquared Ltd.
- Assembly Biosciences
- Swiss National Science Foundation
- Seattle Children's Hospital
- Baylor University
- China Academy of Chinese Medical Sciences
- Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran
- University of Southern California
- University of Zurich
- Stony Brook University
- Wenzhou Medical University
- University of California, Irvine
- University of California, San Francisco
- University of Colorado, Denver
- KCRN Research
- Alliance Foundation Trials
- Oklahoma Foundation for Digestive Research
- University of Montreal
- Washington University in St. Louis
- University of Colorado
- Wakunaga Pharmaceutical Co., Ltd.
- Nuvisan Pharma Services
- Provention Bio, Inc.
Organization Involved with Other Experimental Indications (31)
- Roxane Laboratories
- VSL Pharmaceuticals
- Maastricht University
- Atlantic Health System
- Case Western Reserve University
- Cedars-Sinai Medical Center
- Hong Kong Baptist University
- Indiana University
- New York University
- Radboud University
- Texas A&M University
- University of Dundee
- University of Padova
- Utrecht University
- Wageningen University
- Chinese University of Hong Kong
- Universita' Cattolica del Sacro Cuore
- Novum Pharmaceutical Research Services
- The University of Hong Kong
- University of Nantes
- University of Perugia
- Arla Foods
- Mauna Kea Technologies
- NASPGHAN Foundation
- Tenovus Scotland
- Government of Finland
- Iscare i.v.f., Czech Republic
- Keimyung University
- Fondazione Schena
- University Clinic Zvezdara
- +1 more